Genetic testing for autism: recent advances and clinical implications

References

• Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, United States, 2006. In: MMWR. Surveillance Summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries/CDC56(1), 12–28 (2006).
   Google Scholar
• Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet.2(12), 943–955 (2001).
   PubMed Web of Science ®Google Scholar
• Monaco AP, Bailey AJ. Autism. The search for susceptibility genes. Lancet358(Suppl.), S3 (2001).
   PubMedGoogle Scholar
• Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature461(7265), 802–808 (2009).
   PubMed Web of Science ®Google Scholar
• Anney R, Klei L, Pinto D et al. A genomewide scan for common alleles affecting risk for autism. Hum. Mol. Genet. DOI: 10.1093/hmg/ddq307 (2010) (Epub ahead of print).
   Google Scholar
• Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J. Med. Genet.46(1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: review and clinical implications. Eur. Child. Adolesc. Psychiatry19(3), 169–178 (2010).
   PubMed Web of Science ®Google Scholar
• Sebat J, Lakshmi B, Malhotra D et al. Strong association of de novo copy number mutations with autism. Science316(5823), 445–449 (2007).
   PubMed Web of Science ®Google Scholar
• Marshall CR, Noor A, Vincent JB et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet.82(2), 477–488 (2008).
   PubMed Web of Science ®Google Scholar
• Bucan M, Abrahams BS, Wang K et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet.5(6), e1000536 (2009).
   PubMed Web of Science ®Google Scholar
• Glessner JT, Wang K, Cai G et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature459(7246), 569–573 (2009).
   PubMed Web of Science ®Google Scholar
• Pinto D, Pagnamenta AT, Klei L et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature466(7304), 368–372 (2010).
   PubMed Web of Science ®Google Scholar
• Mefford HC, Sharp AJ, Baker C et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med.359(16), 1685–1699 (2008).
   PubMed Web of Science ®Google Scholar
• Dykens EM, Sutcliffe JS, Levitt P. Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Ment. Retard. Dev. Disabil. Res. Rev.10(4), 284–291 (2004).
   PubMedGoogle Scholar
• Hogart A, Wu D, LaSalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2–q13. Neurobiol. Dis.38(2), 181–191 (2010).
   PubMedGoogle Scholar
• Miller DT, Shen Y, Weiss LA et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatirc disorders. J. Med. Genet.46(4), 242–248 (2009).
   PubMedGoogle Scholar
• Ben-Shachar S, Lanpher B, German JR et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet.46(6), 382–388 (2009).
   PubMed Web of Science ®Google Scholar
• Weiss LA, Shen Y, Korn JM et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med.358(7), 667–675 (2008).
   PubMed Web of Science ®Google Scholar
• Kumar RA, KaraMohamed S, Sudi J et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet.17(4), 628–638 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenfeld JA, Coppinger J, Bejjani BA et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J. Neurodevelop. Disord.2(1), 26–38 (2010).
   PubMedGoogle Scholar
• Shinawi M, Liu P, Kang SH et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J. Med. Genet.47(5), 332–341 (2010).
   PubMed Web of Science ®Google Scholar
• Manning MA, Cassidy SB, Clericuzio C et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics114(2), 451–457 (2004).
   PubMed Web of Science ®Google Scholar
• Schaefer GB, Mendelsohn NJ. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet. Med.10(4), 301–305 (2008).
   PubMed Web of Science ®Google Scholar
• Shen Y, Dies KA, Holm IA et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics125(4), e727–e735 (2010).
   PubMed Web of Science ®Google Scholar
• Baldwin EL, Lee JY, Blake DM et al. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet. Med.10(6), 415–429 (2008).
   PubMed Web of Science ®Google Scholar
• Hochstenbach R, van Binsbergen E, Engelen J et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur. J. Med. Genet.52(4), 161–169 (2009).
   PubMed Web of Science ®Google Scholar
• Miller DT, Adam MP, Aradhya S et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet.86(5), 749–764 (2010).
   PubMed Web of Science ®Google Scholar
• Alarcon M, Abrahams BS, Stone JL et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet.82(1), 150–159 (2008).
   PubMed Web of Science ®Google Scholar
• Arking DE, Cutler DJ, Brune CW et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet.82(1), 160–164 (2008).
   PubMed Web of Science ®Google Scholar
• Bakkaloglu B, O’Roak BJ, Louvi A et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet.82(1), 165–173 (2008).
   PubMed Web of Science ®Google Scholar
• Kim HG, Kishikawa S, Higgins AW et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet.82(1), 199–207 (2008).
   PubMed Web of Science ®Google Scholar
• Ching MS, Shen Y, Tan WH et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet.153B(4), 937–947 (2010).
   PubMed Web of Science ®Google Scholar
• Morrow EM, Yoo SY, Flavell SW et al. Identifying autism loci and genes by tracing recent shared ancestry. Science321(5886), 218–223 (2008).
   PubMed Web of Science ®Google Scholar
• Durand CM, Betancur C, Boeckers TM et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet.39(1), 25–27 (2007).
   PubMed Web of Science ®Google Scholar
• Moessner R, Marshall CR, Sutcliffe JS et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet.81(6), 1289–1297 (2007).
   PubMed Web of Science ®Google Scholar
• Buxbaum JD, Cai G, Chaste P et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(4), 484–491 (2007).
   PubMed Web of Science ®Google Scholar
• Sallows GO, Graupner TD. Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am. J. Ment. Retard.110(6), 417–438 (2005).
   PubMedGoogle Scholar
• Howlin P, Magiati I, Charman T. Systematic review of early intensive behavioral interventions for children with autism. Am. J. Intellect. Dev. Disabil.114(1), 23–41 (2009).
   PubMedGoogle Scholar
• Magiati I, Charman T, Howlin P. A two-year prospective follow-up study of community-based early intensive behavioural intervention and specialist nursery provision for children with autism spectrum disorders. J. Child Psychol. Psychiatry48(8), 803–812 (2007).
   PubMed Web of Science ®Google Scholar
• Altemeier WA, Altemeier LE. How can early, intensive training help a genetic disorder? Pediatr. Ann.38(3), 167–170, 172 (2009).
   PubMed Web of Science ®Google Scholar
• Ng SB, Buckingham KJ, Lee C et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat. Genet.42(1), 30–35 (2010).
   PubMed Web of Science ®Google Scholar
• Lupski JR, Reid JG, Gonzaga-Jauregui C et al. Whole-genome sequencing in a patient with Charcot–Marie–Tooth neuropathy. N. Engl. J. Med.362(13), 1181–1191 (2010).
   PubMed Web of Science ®Google Scholar
• Ashley EA, Butte AJ, Wheeler MT et al. Clinical assessment incorporating a personal genome. Lancet375(9725), 1525–1535 (2010).
   PubMed Web of Science ®Google Scholar
• McClellan J, King MC. Genomic analysis of mental illness: a changing landscape. JAMA303(24), 2523–2524 (2010).
   PubMed Web of Science ®Google Scholar
• Hoppman-Chaney N, Peterson LM, Klee EW, Middha S, Courteau LK, Ferber MJ. Evaluation of oligonucleotide sequence capture arrays and comparison of next-generation sequencing platforms for use in molecular diagnostics. Clin. Chem.56(8), 1297–306 (2010).
   PubMed Web of Science ®Google Scholar
• Shaw AC, Hennekam RC. Interpreting humanity's genes. Eur. J. Med. Genet.52(6), 379–1380 (2009).
   PubMedGoogle Scholar
• Hudson K, Javitt G, Burke W, Byers P. ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet. Gynecol.110(6), 1392–1395 (2007).
   PubMed Web of Science ®Google Scholar
• Lachance CR, Erby LA, Ford BM, Allen VC Jr, Kaphingst KA. Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet. Med.12(5), 304–312 (2010).
   PubMed Web of Science ®Google Scholar